» Articles » PMID: 33632928

Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection

Abstract

Purpose: Perineural invasion (PNI) is associated with aggressive tumor behavior, recurrence, and metastasis, and can influence the administration of adjuvant treatment. However, standard histopathologic examination has limited sensitivity in detecting PNI and does not provide insights into its mechanistic underpinnings.

Experimental Design: A multivariate Cox regression was performed to validate associations between PNI and survival in 2,029 patients across 12 cancer types. Differential expression and gene set enrichment analysis were used to learn PNI-associated programs. Machine learning models were applied to build a PNI gene expression classifier. A blinded re-review of hematoxylin and eosin (H&E) slides by a board-certified pathologist helped determine whether the classifier could improve occult histopathologic detection of PNI.

Results: PNI associated with both poor overall survival [HR, 1.73; 95% confidence interval (CI), 1.27-2.36; < 0.001] and disease-free survival (HR, 1.79; 95% CI, 1.38-2.32; < 0.001). Neural-like, prosurvival, and invasive programs were enriched in PNI-positive tumors ( < 0.001). Although PNI-associated features likely reflect in part the increased presence of nerves, many differentially expressed genes mapped specifically to malignant cells from single-cell atlases. A PNI gene expression classifier was derived using random forest and evaluated as a tool for occult histopathologic detection. On a blinded H&E re-review of sections initially described as PNI negative, more specimens were reannotated as PNI positive in the high classifier score cohort compared with the low-scoring cohort ( = 0.03, Fisher exact test).

Conclusions: This study provides salient biological insights regarding PNI and demonstrates a role for gene expression classifiers to augment detection of histopathologic features.

Citing Articles

Investigation of the correlation between AGRN expression and perineural invasion in colon cancer.

Chen L, Zhang H, Gao K, Meng F, Yang F, Li J Front Mol Biosci. 2024; 11:1510478.

PMID: 39691475 PMC: 11649504. DOI: 10.3389/fmolb.2024.1510478.


The Crosstalk between Nerves and Cancer-A Poorly Understood Phenomenon and New Possibilities.

Benzaquen D, Lawrence Y, Taussky D, Zwahlen D, Oehler C, Champion A Cancers (Basel). 2024; 16(10).

PMID: 38791953 PMC: 11120349. DOI: 10.3390/cancers16101875.


Dickkopf-1 drives perineural invasion via PI3K-AKT signaling pathway in head and neck squamous cancer.

Wang J, Li Q, Liang F, Du X, Song P, Wu T MedComm (2020). 2024; 5(4):e518.

PMID: 38525111 PMC: 10959454. DOI: 10.1002/mco2.518.


Combining perineural invasion with staging improve the prognostic accuracy in colorectal cancer: a retrospective cohort study.

Zhang B, Lin Y, Wang C, Chen Z, Huang T, Chen H BMC Cancer. 2023; 23(1):675.

PMID: 37464346 PMC: 10354907. DOI: 10.1186/s12885-023-11114-8.


Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy.

Basseville A, Cordier C, Ben Azzouz F, Gouraud W, Lasla H, Panloup F Cancer Res Commun. 2023; 2(8):857-869.

PMID: 36923306 PMC: 10010318. DOI: 10.1158/2767-9764.CRC-21-0090.


References
1.
Cieslik M, Chinnaiyan A . Cancer transcriptome profiling at the juncture of clinical translation. Nat Rev Genet. 2017; 19(2):93-109. DOI: 10.1038/nrg.2017.96. View

2.
Zahalka A, Frenette P . Nerves in cancer. Nat Rev Cancer. 2020; 20(3):143-157. PMC: 7709871. DOI: 10.1038/s41568-019-0237-2. View

3.
Yilmaz A, Sahin Duyar S, Cakir E, Aydin E, Demirag F, Karakaya J . Clinical impact of visceral pleural, lymphovascular and perineural invasion in completely resected non-small cell lung cancer. Eur J Cardiothorac Surg. 2011; 40(3):664-70. DOI: 10.1016/j.ejcts.2010.12.059. View

4.
Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, Wilkerson M . Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17(1):98-110. PMC: 2818769. DOI: 10.1016/j.ccr.2009.12.020. View

5.
Venkataramani V, Tanev D, Strahle C, Studier-Fischer A, Fankhauser L, Kessler T . Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature. 2019; 573(7775):532-538. DOI: 10.1038/s41586-019-1564-x. View